UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C. 20549
                          FORM 10-QSB/A

(Mark One)

[X]                          QUARTERLY REPORT PURSUANT TO
                             SECTION 13 OR 15(d) OF THE
                             SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: June 30, 2002

Or

[ ]                          TRANSITION REPORT PURSUANT TO
                             SECTION 13 OR 15(d) OF THE
                             SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to _____________

Commission File Number: 000-33187

                       CareDecision Corporation
        (Exact name of registrant as specified in its charter)

             Nevada                            91-2105842
 (State or other jurisdiction of  (I.R.S. Employer Identification No.)
 incorporation or organization)

 2 Penn Plaza, 15th Floor, Suite                  10121
      1500-53, New York, NY                     (Zip Code)
 (Address of principal executive offices)

                         (212) 292-4959
      (Registrant's telephone number, including area code)

 ATR Search Corporation, 29 E. 31st Street, 2nd Floor, New York, NY 10016
 ( Former name, former address and former fiscal year, if changed since
                             last report)

 Indicate by check mark whether the registrant (1) has filed all
   reports required to be filed by Section 13 or 15(d) of the
 Securities Exchange Act of 1934 during the preceding 12 months
 (or for such shorter period that the registrant was required to
   file such reports), and (2) has been subject to such filing
               requirements for the past 90 days.
                         Yes [X] No [ ]

  APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS
                DURING THE PRECEDING FIVE YEARS:
   Indicate by check mark whether the registrant has filed all
documents and reports required to be filed by Sections 12, 13 or
 15(d) of the Securities Exchange Act of 1934 subsequent to the
  distribution of securities under a plan confirmed by a court.
                         Yes [ ] No [ ]

              APPLICABLE ONLY TO CORPORATE ISSUERS:
The number of shares outstanding of each of the issuer's classes
     of common stock as of the most recent practicable date:
                           34,195,000


/1/


                         CareDecision Corporation
                     [formerly ATR Search Corporation]
                       (a Development Stage Company)


                             Table of Contents

                                                                       Page

PART I - FINANCIAL INFORMATION

  Item 1. Financial Statements

    Consolidated Balance Sheet June 30, 2002 (unaudited)                 4

    Consolidated Statements of Operations For the Three Months           5
    Ended June 30, 2002 and 2001 (unaudited) and For the Six
    Months Ended June 30, 2002 and 2001 (unaudited) and For the
    Period July 6, 2000 (Inception) to June 30, 2002 (unaudited)

    Consolidated Statements of Cash Flows For the Six Months             6
    Ended June 30, 2002 and 2001 (unaudited) and For the Period
    July 6, 2000 (Inception) to June 30, 2002 (unaudited)

    Notes to Financial Statements                                        7

  Item 2. Management's Discussion and Plan of Operation                 10

PART II - OTHER INFORMATION

Item 6. Exhibits                                                        12

SIGNATURES                                                              13


/2/


                    CareDecision Corporation
                [formerly ATR Search Corporation]
                  (a Development Stage Company)

                   Consolidated Balance Sheet
                              as of
                    June 30, 2002 (unaudited)

                               and

              Consolidated Statements of Operations
                               and
                           Cash Flows
               for the Three and Six Months Ended
               June 30, 2002 and 2001 (unaudited),
                       and For the Period
      July 6, 2000 (Inception) to June 30, 2002 (unaudited)


/3/


                         CareDecision Corporation
                     [formerly ATR Search Corporation]
                       (a Development Stage Company)
                        Consolidated Balance Sheet
                                (unaudited)



                                                            June 30,
Assets                                                        2002
                                                           ----------
Current assets:
  Cash                                                     $  303,599
  Notes receivable                                             24,900
                                                           ----------
     Total current assets                                     328,499
                                                           ----------

Fixed assets, net                                              27,857

Intellectual property, net                                  1,097,500

Investment in subsidiary                                      229,899
                                                           ----------
                                                           $1,683,755
                                                           ==========

Liabilities and Stockholders' Equity

Current liabilities:
  Notes payable                                            $  537,573
  Notes payable - officer                                      40,000
                                                           ----------
     Total current liabilities                                577,573
                                                           ----------

Stockholders' equity:
  Common stock, $0.001 par value; 100,000,000 shares
   authorized, 34,195,000 shares issued and outstanding        34,195
  Additional paid-in capital                                2,081,095
  (Deficit) accumulated during development stage           (1,009,108)
                                                           ----------
                                                            1,106,182
                                                           ----------
                                                           $1,683,755
                                                           ==========



 The accompanying notes are an integral part of these financial statements.


/4/


                           CareDecision Corporation
                       [formerly ATR Search Corporation]
                         (a Development Stage Company)
                     Consolidated Statements of Operations
                                  (unaudited)


                          For three months     For six months    July 6, 2000
                           ended June 30,      ended June 30,   (inception) to
                           --------------     ----------------      June 30,
                            2002      2001      2002     2001         2002
                           ------    ------   -------   -------  -------------

Revenue                    $  674    $    -   $ 1,055   $     -  $       1,055
                           ------    ------   -------   -------  -------------

Expenses:
 General &                293,720         -   592,295     4,974        607,486
  administrative expenses
 Consulting expenses            -         -         -         -        325,000
 Depreciation&amortization      -         -     1,393         -         70,393
                           ------    ------   -------   -------  -------------
   Total expenses         293,720         -   593,688     4,974      1,002,879
                           ------    ------   -------   -------  -------------

Other income (expense):
 Interest income                -         -       967         -            967
 Interest expense               -         -    (8,251)        -         (8,251)
                           ------    ------   -------   -------  -------------
Net (loss)              $(293,046)   $    - $(599,917)  $(4,974) $  (1,009,108)
                           ======    ======   =======   =======  =============

Weighted average number of
 common shares outstanding
 basic & fully diluted 21,891,703 16,100,000 10,822,178 7,983,836
                        ========= ========== ========== =========

Net (loss) per share
 basic & fully diluted     $(0.01)   $    -   $ (0.06)  $ (0.00)
                           ======    ======   =======   =======



 The accompanying notes are an integral part of these financial statements.


/5/


                          CareDecision Corporation
                      [formerly ATR Search Corporation]
                        (a Development Stage Company)
                    Consolidated Statements of Cash Flows
                                  (unaudited)


                                     For the six months ended   July 6, 2000
                                            June 30,           (inception) to
                                     ------------------------      June 30,
                                         2002        2001            2002
                                      ----------  ----------     ------------
Cash flows from operating activities
Net (loss)                            $ (599,917) $        -     $ (1,009,108)
Shares issued for services               409,446           -          689,641
Depreciation and amortization              1,393           -           70,393
Adjustments to reconcile net (loss) to
 net cash (used) by operating activities:
  (Increase) in notes receivable         (24,900)          -          (24,900)
Net cash (used) by                    ----------  ----------     ------------
 operating activities                   (213,978)          -         (273,974)

                                      ----------  ----------     ------------
Cash flows from investing activities           -           -                -
                                      ----------  ----------     ------------

Cash flows from financing activities
  Increase in notes payable              537,573           -          537,573
  (Decrease) in notes payable-officer    (20,000)          -           40,000
Net cash provided by                  ----------  ----------     ------------
 financing activities                    517,573           -          577,573
                                      ----------  ----------     ------------

Net increase in cash                     303,595           -          303,599
Cash - beginning                               4           -                -
                                      ----------  ----------     ------------
Cash - ending                         $  303,599  $        -     $    303,599
                                      ==========  ==========     ============

Supplemental disclosures:
  Interest paid                       $        -  $        -     $          -
                                      ==========  ==========     ============
  Income taxes paid                   $        -  $        -     $          -
                                      ==========  ==========     ============

Non-cash transactions:
 Shares issued for services provided  $  409,466  $        -     $    689,641
                                      ==========  ==========     ============
 Number of shares issued for services 12,440,000           -       12,444,000
                                      ==========  ==========     ============



 The accompanying notes are an integral part of these financial statements.


/6/


                    CareDecision Corporation
                [formerly ATR Search Corporation]
                  (a Development Stage Company)
                              Notes

Note 1 - Basis of presentation

The  consolidated  interim financial statements included  herein,
presented  in  accordance with United States  generally  accepted
accounting  principles  and  stated  in  US  dollars,  have  been
prepared by the Company, without audit, pursuant to the rules and
regulations  of the Securities and Exchange Commission.   Certain
information   and  footnote  disclosures  normally  included   in
financial   statements  prepared  in  accordance  with  generally
accepted  accounting  principles have been condensed  or  omitted
pursuant  to  such  rules and regulations, although  the  Company
believes   that  the  disclosures  are  adequate  to   make   the
information presented not misleading.

These  statements reflect all adjustments, consisting  of  normal
recurring  adjustments, which, in the opinion of management,  are
necessary  for  fair  presentation of the  information  contained
therein.   It  is  suggested  that  these  consolidated   interim
financial statements be read in conjunction with the consolidated
financial statements of the Company for the period ended December
31, 2001 and notes thereto included in the Company's Form 10-KSB.
The   Company  follows  the  same  accounting  policies  in   the
preparation of consolidated interim reports.

Results  of operations for the interim periods are not indicative
of annual results.

Note 2 - Going concern

The accompanying financial statements have been prepared assuming
that  the  Company  will  continue  as  a  going  concern,  which
contemplates the recoverability of assets and the satisfaction of
liabilities in the normal course of business. As noted above, the
Company is in the development stage and, accordingly, has not yet
generated  a  proven history of operations. Since its  inception,
the   Company   has  been  engaged  substantially  in   financing
activities and developing its product line, incurring substantial
costs and expenses. As a result, the Company incurred accumulated
net losses from July 6, 2000 (inception) through the period ended
June  30,  2002  of  $(1,009,108).  In  addition,  the  Company's
development  activities  since inception  have  been  financially
sustained by capital contributions.

The  ability  of  the Company to continue as a going  concern  is
dependent upon its ability to raise additional capital  from  the
sale  of  common  stock  and,  ultimately,  the  achievement   of
significant   operating   results.  The  accompanying   financial
statements do not include any adjustments that might be  required
should  the Company be unable to recover the value of its  assets
or satisfy its liabilities.

Note 3 - Notes receivable

On  January  15, 2002, the Company loaned an officer a  total  of
$15,000  which is due in one year at an interest rate of  8%  per
annum.

On  June  1, 2002, the Company loaned CareDecision.net,  Inc.,  a
private corporation that has completed several transactions  with
the Company, and was once managed by several beneficial owners of
the Company, a total of $9,900 which is due on May 31, 2002 at an
interest rate of 8% per annum.

During the period ended June 30, 2002, the total interest income
is $967.

Note 4 - Fixed assets

As  of June 30, 2002 the Company received the following equipment
in the amount of $27,857 from Keith Berman, a beneficial owner of
the  Company.  Depreciation expense totaled $1,393 for  the  six-
month period ended June 30, 2002.


/7/


                    CareDecision Corporation
                [formerly ATR Search Corporation]
                  (a Development Stage Company)
                              Notes

Note 5 - Intellectual property

During  the  period  ended June 30, 2002,  the  Company  acquired
Intellectual  Property  from  CareDecision.net, Inc,   a  private
corporation  that  has completed  several transactions  with  the
Company, and was once managed by several beneficial owners of the
Company.   Pursuant  to the    agreement, the     Company    paid
CareDecision.net, Inc. the sum of $187,500 with 700,000 shares of
the Company's $0.001 par value preferred stock.

Note 6 - Investment in Care Technologies, LLC

On June 21, 2001, the Company entered into an agreement with Care
Technologies, LLC whereby the Company sold all of the assets  and
liabilities  of  the Company in exchange for a 10%  ownership  of
Care Technologies, LLC.  The investment was recorded at $229,899,
being  the  fair value of the Company's assets on the acquisition
date.

Note 7 - Notes payable

On  January  15,  2002, the Company received $40,000  from  Keith
Berman,  a  beneficial  owner of the Company,  which  is  due  on
December  31,  2003 and accrued interest at 8%  per  annum.   The
principal  and accrued interest can be converted  at  a  rate  of
$0.10 per share.

On  April 23, 2002, the Company received $475,000 from  M  and  E
Equities, LLC which is due in two years at an interest rate of 9%
per  annum.   The  principal and interest  of  the  note  can  be
converted  into  five shares of the Company's  $0.001  par  value
common  stock for each $1 of debt.  This note is secured  by  all
the  assets  of  the  Company  to  include  accounts  receivable,
inventory, fixed assets, and intangible assets.

During  the  period ended June 30, 2002, the Company  received  a
total  of $62,573 from various entities and individuals which  is
due upon demand and accrued interest at a rate of 0%.

During the six-month period ended June 30, 2002, the Company  had
interest expense of $8,251.

Note 8 - Stockholder's equity

During the period ended June 30, 2002, the Company issued a total
of  12,444,000  shares of the Company's $0.001 par  value  common
stock for various services at prices ranging from $0.001 to $1.30
per share.

There have been no other issuances of common stock.

Note 9 - Related party transactions

On  June  1, 2002, the Company loaned CareDecision.net,  Inc.,  a
private corporation that has completed several transactions  with
the Company, and was once managed by several beneficial owners of
the Company, a  total  of $9,900 which is due on May 31, 2002  at
an interest rate of 8% per annum.

As  of June 30, 2002 the Company received the following equipment
in the amount of $27,857 from Keith Berman, a beneficial owner of
the  Company.  Depreciation expense totaled $1,393 for  the  six-
month period ended June 30, 2002.

During  the  period  ended June 30, 2002,  the  Company  acquired
Intellectual  Property  from  CareDecision.net, Inc,  a   private
corporation that has  completed  several  transactions  with  the
Company, and was once managed by several beneficial owners of the
Company.   Pursuant  to  the   agreement,  the    Company    paid
CareDecision.net, Inc. the sum of $187,500 with 700,000 shares of
the Company's $0.001 par value preferred stock.


/8/


                    CareDecision Corporation
                [formerly ATR Search Corporation]
                  (a Development Stage Company)
                              Notes

On  January  15,  2002, the Company received $40,000  from  Keith
Berman,  a  beneficial  owner of the Company,  which  is  due  on
December  31,  2003 and accrued interest at 8%  per  annum.   The
principal  and accrued interest can be converted  at  a  rate  of
$0.10 per share.

Note 10 - Warrants

As of March 7, 2002, the Company issued 62,500 warrants to CRS, a
shareholder of the Company, to purchase the Company's $0.001  par
value  common stock on a one-for-one basis.  The warrant exercise
price  is  $0.10 per share of common stock and substantially  all
warrants will expire on or before March 7, 2007.

As  of  June 30, 2002, no warrants have been exercised to acquire
additional shares of common stock.

Note  11  -  Reverse acquisitions agreement with  Medicius,  Inc.
(MED)

On  June 21, 2001, the Company entered into an agreement with MED
whereby  the  Company acquired all of the issued and  outstanding
common  stock of NDI in exchange for 38,043,863 voting shares  of
the Company's $0.001 par value common stock.  The acquisition was
accounted  for  using  the  purchase  method  of  accounting   as
applicable   to   reverse   acquisitions   because   the   former
stockholders  of  the MED controlled the Company's  common  stock
immediately  upon conclusion of the transaction.   Under  reverse
acquisition accounting, the post-acquisition entity was accounted
for  as  a recapitalization of MED.  The common stock issued  was
recorded  at $0, being the fair value of the Company's assets  on
the acquisition date.

The  continuing company has retained December 31  as  its  fiscal
year end.

Note 12 - Subsequent events

On   August  2,  2002,  the  Company  amended  its  articles   of
incorporation  to  change  the  Company's  name  to  CareDecision
Corporation  and increase its authorized capital  to  200,000,000
shares  of  the  common  stock with a par  value  of  $0.001  and
5,000,000  shares  of the preferred stock with  a  par  value  of
$0.001.

On  August  1, 2002, the Company issued 3,000,000 shares  to  Ken
Lowman for consulting services rendered.

On August 9, 2002, the Company issued 2,000,000 shares to Barbara
Asbell,  a  shareholder of the Company, for  consulting  services
rendered.


/9/


      Item 2. Management's Discussion and Plan of Operation

Forward-Looking Statements

  This Quarterly Report contains forward-looking statements
about our business, financial condition and prospects that
reflect our assumptions and beliefs based on information
currently available.  We can give no assurance that the
expectations indicated by such forward-looking statements will be
realized.  If any of our assumptions should prove incorrect, or
if any of the risks and uncertainties underlying such
expectations should materialize, our actual results may differ
materially from those indicated by the forward-looking
statements.

  The key factors that are not within our control and that may
have a direct bearing on operating results include, but are not
limited to, acceptance of our services, our ability to expand our
customer base, our ability to raise capital in the future, the
retention of key employees and changes in the regulation of our
industry.  There may be other risks and circumstances that we are
unable to predict.  When used in this Quarterly Report, words
such as,  "believes,"  "expects,"  "intends,"  "plans,"
"anticipates,"  "estimates" and similar expressions are intended
to identify forward-looking statements, although there may be
certain forward-looking statements not accompanied by such
expressions.  All forward-looking statements are intended to be
covered by the safe harbor created by Section 21E of the
Securities Exchange Act of 1934.

General

  We were formed as a Nevada corporation under the name ATR
Search Corporation ("ATR") on March 2, 2001.  On June 28, 2002 we
filed a report on Form 8-K with the Securities and Exchange
Commission, incorporated herein by reference, whereby Medicius,
Inc. ("Medicius"), a Nevada corporation, merged with and into
ATR.  Pursuant to the terms of the merger agreement, ATR obtained
the operations of Medicius.

  We adopted Medicius' business model, which is to provide
enhanced information technology (IT) to physicians at the point
of clinical decision because we believe that the growth of the e-
healthcare industry will far outpace that of our previous
business model, which was to provide IT technology professionals
to businesses on a part-time or full-time basis.  With the demise
of many .com companies over the past few years the market has
become saturated with unemployed IT professionals.  It is the
opinion of management that this will act to drive down the fees
we can obtain from the placement of these professionals and
reduce the number of companies desirous of engaging our services.
On the other hand, the Medicius software systems, communication
tools and suite of software applications obtained through our
merger, permits a physician to request critical patient medical
and/or medication information via the Web on a Microsoft Windows
CE-based PDA at, or prior to the point-of-care.

  The system captures and displays the requested information,
and overlays formulaic medical treatment protocols and medical
step therapies, creating not only a patient specific historical
medical chart, but also suggested treatment alternatives,
approved medications and diagnosis specific protocols.
Utilization of this system by the practicing physician enhances
clinical decision-making, improves physician productivity,
insures formulary compliance, reduces the cost of healthcare and
positively impacts the care provided to the patient.

  On August 2, 2002 we filed amended articles of incorporation
with the state of Nevada (see exhibit 3.1c, previously filed with
the Commission) to change the name of our company to CareDecision
Corporation and increase our number of authorized common shares
to 200,000,000.


/10/


Results of Operations

  We generated $1,055 in revenues for the six-month period ended
June 30, 2002.  Our future revenues will be reliant on the
acceptance of our software systems, communication tools and suite
of software applications.

  Total operating expenses for the six months ended June 30,
2002 were $593,688 and $1,002,879 since inception.  Total
operating expenses for the six-month period ended June 30, 2002
and since inception were entirely related to general and
administrative expenses, consulting fees, depreciation and
amortization, and organizational costs.

Future Business

  The elements of our future business strategy include:
expanding geographically into key markets through a combination
of opening new offices and developing relationships with clients
to generate demand for our services; recruiting qualified,
medical software and other technical personnel to perform
technical, implementation and support duties as contracts are
entered into, although there can be no assurance that any such
contracts will be secured; and pursuing entry into new markets
complementary to our proposed operations.  Future operations are
dependent upon our ability to implement our business and
marketing strategies and to establish relationships and contracts
with health insurers and HMOs to provide our e-healthcare
products and services.

Liquidity and Capital Resources

  We believe our cash on hand of $303,599 will be sufficient to
fund ongoing fiscal 2002 and 2003 operations and provide for our
working capital needs, however, we have negative working capital
of $249,074.  Our accountant has issued a note concerning our
ability to continue as a going concern.  As we are still
considered to be in the development stage, our prospects of
continuing as a going concern are contingent upon our ability to
achieve and maintain profitable operations.  Revenues generated
over and above expenses will be used for further development of
our services, to provide financing for marketing and promotion,
to secure additional customers, equipment and personnel, and for
other working capital purposes.

  To date, we have financed our cash flow requirements through a
public issuance of common stock and through the issuance of
notes.  During our normal course of business, we will experience
net negative cash flows from operations, pending receipt of
revenues.  Further, we may be required to obtain financing to
fund operations through additional common stock offerings and
bank borrowings, to the extent available, or to obtain additional
financing to the extent necessary to augment our available
working capital.

  All investor inquiries should be directed via mail to Mr.
Robert Cox, President, CareDecision Corp.   2 Penn Plaza, 15th
Floor, Suite 1500-53, New York, New York 10121.


/11/


                   PART II - OTHER INFORMATION


Item 6a. Exhibits



  Exhibit  Name and/or Identification of Exhibit
  Number
   3.1     Articles of Incorporation & By-Laws
                 (a) Articles of Incorporation of the Company
                 filed March 2, 2001.  Incorporated by
                 reference to the exhibits to the Company's
                 General Form For Registration Of Securities
                 Of Small Business Issuers on Form 10-SB,
                 previously filed with the Commission.
                 (b) Certificate of Amendment to the Articles
                 of Incorporation of the Company filed May 9,
                 2001.  Incorporated by reference to the
                 exhibits to the Company's General Form For
                 Registration Of Securities Of Small Business
                 Issuers on Form 10-SB, previously filed with
                 the Commission.
                 (c) Certificate of Amendment to the Articles
                 of Incorporation of the Company filed August
                 2, 2002.  Incorporated by reference to the
                 exhibits to the Company's June 30, 2002
                 Quarterly Report on Form 10-QSB, previously
                 filed with the Commission.
   3.2           By-Laws of the Company adopted March 16,
                 2001.  Incorporated by reference to the
                 exhibits to the Company's General Form For
                 Registration Of Securities Of Small Business
                 Issuers on Form 10-SB, previously filed with
                 the Commission.
  99.1           Certification under Section 906 of the
                 Sarbanes-Oxley Act (18 U.S.C. SECTION 1350)


Item 6b. Reports on Form 8-K

(a) Items 5 and 7 on Form 8-K filed with the Commission on June
    28, 2002.


/12/


                           SIGNATURES

Pursuant to the requirements of the Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.

                    CareDecision Corporation
-----------------------------------------------------------------
                          (Registrant)




Date: August 28, 2002
      ---------------



By: /s/ Robert Cox
    -----------------------------
    Robert Cox, President and CEO







Date: August 28, 2002
      ---------------



By: /s/ Michael Vogel
    --------------------------------
    Michael Vogel, Treasurer and CFO


/13/